11/15/2024
4:28 PM | Leap Therapeutics (Issuer)
Mirabelli Christopher (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/15/2024
4:29 PM | LAWLOR AUGUSTINE (Reporting)
Leap Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/15/2024
4:30 PM | Leap Therapeutics (Issuer)
ONSI DOUGLAS E (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/15/2024
4:31 PM | CAVANAUGH JAMES H (Reporting)
Leap Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/14/2024
5:07 AM | BALYASNY ASSET MANAGEMENT L.P. (Filed by)
Leap Therapeutics (Subject)
| Form SC 13G | |
11/13/2024
6:10 AM | Leap Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/13/2024
5:50 AM | Leap Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
10/31/2024
5:29 PM | BeiGene, Ltd. (Filed by)
Leap Therapeutics (Subject)
| Form SC 13D/A | |
10/31/2024
4:40 PM | BeiGene, Ltd. (Filed by)
Leap Therapeutics (Subject)
| Form SCHEDULE 13D/A | |
10/04/2024
4:22 PM | Leap Therapeutics (Issuer)
Mashiach Nissim (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/04/2024
4:23 PM | Baum Jason (Reporting)
Leap Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
|
10/04/2024
4:23 PM | Leap Therapeutics (Issuer)
Mirabelli Christopher (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/04/2024
4:23 PM | CAVANAUGH JAMES H (Reporting)
Leap Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/04/2024
4:24 PM | Dietz Thomas John (Reporting)
Leap Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/04/2024
4:24 PM | LAWLOR AUGUSTINE (Reporting)
Leap Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/04/2024
4:24 PM | Leap Therapeutics (Issuer)
O'Mahony John Mark (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/04/2024
4:24 PM | Leap Therapeutics (Issuer)
LI WILLIAM (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/04/2024
4:25 PM | Leap Therapeutics (Issuer)
LOSCALZO JOSEPH (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/04/2024
4:25 PM | Leap Therapeutics (Issuer)
ONSI DOUGLAS E (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/04/2024
4:25 PM | Leap Therapeutics (Issuer)
Martin Patricia A. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/04/2024
4:26 PM | Leap Therapeutics (Issuer)
Richard Christian M (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/04/2024
4:27 PM | Leap Therapeutics (Issuer)
Schilsky Richard (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/04/2024
4:29 PM | Leap Therapeutics (Issuer)
Sirard Cynthia (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/04/2024
4:29 PM | Granfield Christine (Reporting)
Leap Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/30/2024
6:30 AM | Leap Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/12/2024
6:10 AM | Leap Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/12/2024
5:50 AM | Leap Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
07/08/2024
3:48 PM | Leap Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/23/2024
11:15 PM | Leap Therapeutics (Filer)
| Form EFFECT | |
05/13/2024
6:10 AM | Leap Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/13/2024
5:50 AM | Leap Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/10/2024
4:01 PM | Leap Therapeutics (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
05/09/2024
11:15 PM | Leap Therapeutics (Filer)
| Form EFFECT | |
04/29/2024
3:34 PM | Leap Therapeutics (Filer)
| Form DEFA14A | |
04/29/2024
3:37 PM | Leap Therapeutics (Filer)
| Form ARS | |
04/25/2024
7:39 PM | Leap Therapeutics (Subject)
Samsara BioCapital, L.P. (Filed by)
| Form SC 13G | |
04/19/2024
3:31 PM | GILEAD SCIENCES, INC. (Reporting)
Leap Therapeutics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
04/19/2024
3:31 PM | GILEAD SCIENCES, INC. (Filed by)
Leap Therapeutics (Subject)
| Form SC 13G | |
04/11/2024
7:42 AM | Leap Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/18/2024
6:41 AM | Leap Therapeutics (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
03/18/2024
6:10 AM | Leap Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
Kickstart Your 2025 Financial Resolutions with Just $30 (Ad) Happy New Year! As we welcome 2025, it’s the perfect time to set your financial goals and build a prosperous future.
Ready to transform your investments and achieve your financial resolutions?
Imagine generating a reliable income stream from stocks priced under $30. Our latest guide introduces straightforward options strategies tailored for everyday investors, helping you turn well-known companies like Ford and Intel into consistent monthly income sources. Claim Your Free Report Now: “Options Made Simple – 2 Affordable Stocks for Monthly Income” |
03/18/2024
5:50 AM | Leap Therapeutics (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
01/31/2024
8:34 PM | LAWLOR AUGUSTINE (Reporting)
Leap Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/31/2024
8:34 PM | Leap Therapeutics (Issuer)
Martin Patricia A. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/31/2024
8:34 PM | Leap Therapeutics (Issuer)
Sirard Cynthia (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/31/2024
8:34 PM | Leap Therapeutics (Issuer)
O'Mahony John Mark (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/31/2024
8:35 PM | Leap Therapeutics (Issuer)
Richard Christian M (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/31/2024
8:35 PM | Baum Jason (Reporting)
Leap Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/31/2024
8:35 PM | Granfield Christine (Reporting)
Leap Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/31/2024
8:36 PM | Leap Therapeutics (Issuer)
Schilsky Richard (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/31/2024
8:36 PM | Dietz Thomas John (Reporting)
Leap Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/31/2024
8:37 PM | Leap Therapeutics (Issuer)
Mashiach Nissim (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/31/2024
8:31 PM | CAVANAUGH JAMES H (Reporting)
Leap Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/31/2024
8:32 PM | Leap Therapeutics (Issuer)
LI WILLIAM (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/31/2024
8:32 PM | Leap Therapeutics (Issuer)
ONSI DOUGLAS E (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/31/2024
8:33 PM | Leap Therapeutics (Issuer)
Mirabelli Christopher (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/31/2024
8:33 PM | Leap Therapeutics (Issuer)
LOSCALZO JOSEPH (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/30/2024
7:37 PM | Leap Therapeutics (Issuer)
ONSI DOUGLAS E (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/30/2024
7:38 PM | LAWLOR AUGUSTINE (Reporting)
Leap Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/30/2024
7:39 PM | Leap Therapeutics (Issuer)
Sirard Cynthia (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/30/2024
7:41 PM | Leap Therapeutics (Issuer)
O'Mahony John Mark (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/30/2024
7:42 PM | Leap Therapeutics (Issuer)
Mirabelli Christopher (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/23/2024
4:28 PM | Leap Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
